Metabolic Impact of Intermittent CPAP
NCT02824263
Apnea, Dyssomnias
Baltimore, Maryland, United States
View Trial DetailsNCT Number: NCT00466011
Introduction: The full night polysomnography (PSG) in sleep lab is the gold standard to Obstructive Sleep Apnea (OSA) diagnosis. However, there is a need to evaluate simple and accurate home diagnostic equipment that can reliably detect or exclude OSA. The aim of our study was to evaluate if an ambulatory portable monitor (SD) is accurate to measure apnea-hypopnea index (AHI) in OSA patients referred to a Sleep Lab. Methods: Patients with clinical suspicion of OSA were selected. Three-order randomized evaluations had been performed within a period of two weeks: the 1) SD (Stardust®, Respironics, Inc, USA) was used at patients home (SD home), 2) SD was used simultaneously with PSG in the sleep lab (SD+PSG lab) and 3) PSG was performed without the use of SD (PSG lab). Four AHI were generated and analyzed: AHI from SD home, AHI from SD of SD+PSG lab, AHI from PSG of PSG+SD lab and AHI from PSG lab. The analyses of SDs and PSGs recordings were performed by two blinded technicians.
Looking for future studies?
Notify Me21 year–65 year
All sexes
Observational
AFIP, São Paulo, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeAssociação Fundo de Incentivo à Pesquisa
Other
Acronym: Stardust
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02824263
Apnea, Dyssomnias
Baltimore, Maryland, United States
View Trial DetailsNCT04760002
Apnea, Dyssomnias
Copenhagen, Denmark
View Trial DetailsNCT03736382
Apnea, Central Nervous System Diseases
Detroit, Michigan, United States
View Trial DetailsNCT06566482
Apnea, Dexmedetomidine
Beijing, Beijing Municipality, China
View Trial Details